Which corneal transplant is best? 1,000-Patient study aims to find out
NCT ID NCT06859411
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will compare how well patients see after three types of corneal transplants: DSAEK, UT-DSAEK, and DMEK. Researchers will follow 1,000 people who had surgery for Fuchs' endothelial corneal dystrophy or pseudophakic bullous keratopathy. They will measure vision, cell counts, and complications to see which technique works best over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors choose the best corneal transplant technique for each patient, improving vision outcomes.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by other factors. It only looks back at past surgeries, so it cannot prove one technique is definitively better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUCHS ENDOTHELIAL CORNEAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHR Metz-Thionville Hopital de Mercy
RECRUITINGMetz, 57085, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye drops offer a new way to treat fuchs dystrophy?
- Fuchs dystrophy and cataract surgery: does the cornea behave differently?
- One shot to see clearly: cell therapy takes on corneal edema
- Could a glaucoma eye drop also heal the cornea?
- Corneal polishing study aims to improve cell therapy for fuchs dystrophy
- New eye drops aim to speed vision recovery after cornea surgery